Company Profile
PMV Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- PMVP
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.18 USD (-4.84%)
Close
Last updated: July 27, 2026
62.9M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, PMVP closed down 4.84% at $1.18. No new same-company headline was identified in the current news window.
Company overview
Business overview
PMV Pharmaceuticals is an oncology company focused on p53 biology and precision cancer medicine. Its platform aims to unlock one of the most studied tumor-suppressor pathways in oncology.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, PMV sits in specialty oncology biotechnology.
Business Model Characteristics
The company depends on translational validation, clinical data, and the chance to build a differentiated p53 franchise.
Position Within the Biotechnology Landscape
PMV is a catalyst-sensitive oncology name whose stock is highly tied to proof-of-concept and mechanistic confidence.
Future catalysts
Near-term attention for PMV Pharmaceuticals is likely to stay on its latest development priorities. The current setup is really about Food and Drug Administration for the treatment of TP53 Y220C positive ovarian cancer New England Journal of Medicine published first-in-human rezatapopt data showing selective.... That is where the next meaningful signal is most likely to come from.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK
GSK · Source: GSK plc
- 02
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
LEGN · Source: Legend Biotech Corporation
- 03
- 04
- 05
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of PMV Pharmaceuticals (PMVP)?
PMV Pharmaceuticals (PMVP) most recently closed at 1.18 USD, a -4.84% move versus the previous session.
What is the market cap of PMV Pharmaceuticals (PMVP)?
PMV Pharmaceuticals currently has a market capitalization of 62.9M USD on BioPharmSignal.
What does PMV Pharmaceuticals do?
PMV Pharmaceuticals is an oncology company focused on p53 biology and precision cancer medicine. Its platform aims to unlock one of the most studied tumor-suppressor pathways in oncology.
On which exchange is PMVP stock listed?
PMV Pharmaceuticals (PMVP) is associated with NASDAQ, United States, Biopharma.
What is Pharmaceuticals?
Near-term attention for PMV Pharmaceuticals is likely to stay on its latest development priorities.
Which conditions is PMV Pharmaceuticals targeting with Pharmaceuticals?
PMV Pharmaceuticals is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does PMV Pharmaceuticals describe recent progress with Pharmaceuticals?
Near-term attention for PMV Pharmaceuticals is likely to stay on its latest development priorities.
What is Near-term?
Near-term attention for PMV Pharmaceuticals is likely to stay on its latest development priorities.